Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation

Alexandra S Whale, Jim F Huggett, Simon Cowen, Valerie Speirs, Jacqui Shaw, Stephen Ellison, Carole A Foy, Daniel J Scott

Research output: Contribution to journalArticle

214 Citations (Scopus)
4 Downloads (Pure)

Abstract

One of the benefits of Digital PCR (dPCR) is the potential for unparalleled precision enabling smaller fold change measurements. An example of an assessment that could benefit from such improved precision is the measurement of tumour-associated copy number variation (CNV) in the cell free DNA (cfDNA) fraction of patient blood plasma. To investigate the potential precision of dPCR and compare it with the established technique of quantitative PCR (qPCR), we used breast cancer cell lines to investigate HER2 gene amplification and modelled a range of different CNVs. We showed that, with equal experimental replication, dPCR could measure a smaller CNV than qPCR. As dPCR precision is directly dependent upon both the number of replicate measurements and the template concentration, we also developed a method to assist the design of dPCR experiments for measuring CNV. Using an existing model (based on Poisson and binomial distributions) to derive an expression for the variance inherent in dPCR, we produced a power calculation to define the experimental size required to reliably detect a given fold change at a given template concentration. This work will facilitate any future translation of dPCR to key diagnostic applications, such as cancer diagnostics and analysis of cfDNA.

Original languageEnglish
Article numbere82
Number of pages9
JournalNucleic Acids Research
Volume40
Issue number11
DOIs
Publication statusPublished - Jun 2012

Fingerprint

Microfluidics
Polymerase Chain Reaction
Binomial Distribution
Poisson Distribution
erbB-2 Genes
Gene Amplification
DNA
Neoplasms
Breast Neoplasms
Cell Line

Keywords

  • Cell Line, Tumor
  • DNA Copy Number Variations
  • DNA, Neoplasm
  • Female
  • Gene Amplification
  • Gene Dosage
  • Genes, erbB-2
  • Humans
  • Microfluidic Analytical Techniques
  • Polymerase Chain Reaction
  • Comparative Study
  • Evaluation Studies
  • Journal Article
  • Research Support, Non-U.S. Gov't

Cite this

Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation. / Whale, Alexandra S; Huggett, Jim F; Cowen, Simon; Speirs, Valerie; Shaw, Jacqui; Ellison, Stephen; Foy, Carole A; Scott, Daniel J.

In: Nucleic Acids Research, Vol. 40, No. 11, e82, 06.2012.

Research output: Contribution to journalArticle

Whale, Alexandra S ; Huggett, Jim F ; Cowen, Simon ; Speirs, Valerie ; Shaw, Jacqui ; Ellison, Stephen ; Foy, Carole A ; Scott, Daniel J. / Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation. In: Nucleic Acids Research. 2012 ; Vol. 40, No. 11.
@article{54cb79a91235439db0007fd74ab340d1,
title = "Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation",
abstract = "One of the benefits of Digital PCR (dPCR) is the potential for unparalleled precision enabling smaller fold change measurements. An example of an assessment that could benefit from such improved precision is the measurement of tumour-associated copy number variation (CNV) in the cell free DNA (cfDNA) fraction of patient blood plasma. To investigate the potential precision of dPCR and compare it with the established technique of quantitative PCR (qPCR), we used breast cancer cell lines to investigate HER2 gene amplification and modelled a range of different CNVs. We showed that, with equal experimental replication, dPCR could measure a smaller CNV than qPCR. As dPCR precision is directly dependent upon both the number of replicate measurements and the template concentration, we also developed a method to assist the design of dPCR experiments for measuring CNV. Using an existing model (based on Poisson and binomial distributions) to derive an expression for the variance inherent in dPCR, we produced a power calculation to define the experimental size required to reliably detect a given fold change at a given template concentration. This work will facilitate any future translation of dPCR to key diagnostic applications, such as cancer diagnostics and analysis of cfDNA.",
keywords = "Cell Line, Tumor, DNA Copy Number Variations, DNA, Neoplasm, Female, Gene Amplification, Gene Dosage, Genes, erbB-2, Humans, Microfluidic Analytical Techniques, Polymerase Chain Reaction, Comparative Study, Evaluation Studies, Journal Article, Research Support, Non-U.S. Gov't",
author = "Whale, {Alexandra S} and Huggett, {Jim F} and Simon Cowen and Valerie Speirs and Jacqui Shaw and Stephen Ellison and Foy, {Carole A} and Scott, {Daniel J}",
note = "ACKNOWLEDGEMENTS The authors would like to acknowledge Dr Malcolm Burns and Dr Alison Devonshire for critical review of the manuscript",
year = "2012",
month = "6",
doi = "10.1093/nar/gks203",
language = "English",
volume = "40",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation

AU - Whale, Alexandra S

AU - Huggett, Jim F

AU - Cowen, Simon

AU - Speirs, Valerie

AU - Shaw, Jacqui

AU - Ellison, Stephen

AU - Foy, Carole A

AU - Scott, Daniel J

N1 - ACKNOWLEDGEMENTS The authors would like to acknowledge Dr Malcolm Burns and Dr Alison Devonshire for critical review of the manuscript

PY - 2012/6

Y1 - 2012/6

N2 - One of the benefits of Digital PCR (dPCR) is the potential for unparalleled precision enabling smaller fold change measurements. An example of an assessment that could benefit from such improved precision is the measurement of tumour-associated copy number variation (CNV) in the cell free DNA (cfDNA) fraction of patient blood plasma. To investigate the potential precision of dPCR and compare it with the established technique of quantitative PCR (qPCR), we used breast cancer cell lines to investigate HER2 gene amplification and modelled a range of different CNVs. We showed that, with equal experimental replication, dPCR could measure a smaller CNV than qPCR. As dPCR precision is directly dependent upon both the number of replicate measurements and the template concentration, we also developed a method to assist the design of dPCR experiments for measuring CNV. Using an existing model (based on Poisson and binomial distributions) to derive an expression for the variance inherent in dPCR, we produced a power calculation to define the experimental size required to reliably detect a given fold change at a given template concentration. This work will facilitate any future translation of dPCR to key diagnostic applications, such as cancer diagnostics and analysis of cfDNA.

AB - One of the benefits of Digital PCR (dPCR) is the potential for unparalleled precision enabling smaller fold change measurements. An example of an assessment that could benefit from such improved precision is the measurement of tumour-associated copy number variation (CNV) in the cell free DNA (cfDNA) fraction of patient blood plasma. To investigate the potential precision of dPCR and compare it with the established technique of quantitative PCR (qPCR), we used breast cancer cell lines to investigate HER2 gene amplification and modelled a range of different CNVs. We showed that, with equal experimental replication, dPCR could measure a smaller CNV than qPCR. As dPCR precision is directly dependent upon both the number of replicate measurements and the template concentration, we also developed a method to assist the design of dPCR experiments for measuring CNV. Using an existing model (based on Poisson and binomial distributions) to derive an expression for the variance inherent in dPCR, we produced a power calculation to define the experimental size required to reliably detect a given fold change at a given template concentration. This work will facilitate any future translation of dPCR to key diagnostic applications, such as cancer diagnostics and analysis of cfDNA.

KW - Cell Line, Tumor

KW - DNA Copy Number Variations

KW - DNA, Neoplasm

KW - Female

KW - Gene Amplification

KW - Gene Dosage

KW - Genes, erbB-2

KW - Humans

KW - Microfluidic Analytical Techniques

KW - Polymerase Chain Reaction

KW - Comparative Study

KW - Evaluation Studies

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1093/nar/gks203

DO - 10.1093/nar/gks203

M3 - Article

VL - 40

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 11

M1 - e82

ER -